Julio Delgado
Barcelona Supercomputing Center(ES)Instituto de Salud Carlos III(ES)European Space Agency(FR)WinnMed(US)Departament de Salut(ES)Hospital Clínic de Barcelona(ES)Gemeente Den Haag(NL)Mayo Clinic in Florida(US)Fundació Clínic per a la Recerca Biomèdica(ES)Centro de Investigación Biomédica en Red de Cáncer(ES)Consorci Institut D'Investigacions Biomediques August Pi I Sunyer(ES)European Space Research Institute(IT)Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i SunyerUniversitat de Barcelona(ES)Universitat Politècnica de Catalunya(ES)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Immunodeficiency and Autoimmune Disorders, Multiple Myeloma Research and Treatments
Most-Cited Works
- → Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia(2014)1,603 cited
- → Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia(2011)992 cited
- → Non-coding recurrent mutations in chronic lymphocytic leukaemia(2015)842 cited
- → Acquired Haemophilia: Review and Meta‐Analysis Focused on Therapy and Prognostic Factors(2003)462 cited
- → The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL(2018)335 cited
- → Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia(2016)329 cited